Biotechnology Reagents Market Report 2025

The biotechnology reagents market size has grown strongly in recent years. It will grow from $85.19 billion in 2024 to $93.01 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to rise in biopharmaceutical development, genomics and proteomics research expansion, drug discovery and development, increasing life sciences research funding, global focus on precision medicine.

The biotechnology reagents market size is expected to see rapid growth in the next few years. It will grow to $137.51 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to single-cell analysis techniques, expansion of synthetic biology, rising importance of glycomics, expansion of cell culture applications, biobanking and biorepository growth, global response to health crises. Major trends in the forecast period include rapid advancements in biotechnology research, technological advances in flow cytometry, focus on stem cell research, demand for crispr-cas9 reagents, customized and specialty reagents, focus on quality control and standardization.

The increasing demand for polymerase chain reaction (PCR) is anticipated to drive the growth of the biotechnology reagents market in the future. PCR is a molecular technique used to amplify small segments of DNA into larger ones, which are essential for diagnosing certain infectious diseases and studying genetic changes. Biotechnology reagents are crucial for maintaining a stable pH during the PCR process, ensuring proper DNA synthesis, which can later be utilized for various genomic studies and diagnostic purposes. For instance, a report published in March 2022 by the Health Security Agency, a UK government body, highlighted that the NHS Test and Trace program incurred substantial costs, with an estimated expenditure of £15.7 billion for the financial year 2021-2022, largely driven by increased demand for both PCR and rapid lateral flow tests. Therefore, the rising demand for PCR is a key factor propelling the growth of the biotechnology reagents market.

The increasing prevalence of chronic diseases is poised to drive the growth of the biotechnology reagents market. Chronic diseases require a multifaceted approach involving individual responsibility, healthcare interventions, and societal measures. Biotechnology reagents serve as essential tools for scientists, enabling them to study, diagnose, and find potential treatments for chronic diseases. A notable projection from the National Library of Medicine indicates a 99.5% increase in the number of individuals aged 50 and older with at least one chronic condition in the US by 2050, emphasizing the growing significance of biotechnology reagents.

Technological advancement emerges as a pivotal trend in the biotechnology reagent market, with major companies focusing on innovation to strengthen their market position. For instance, in April 2022, CN BIO Innovations introduced the PhysioMimix in-a-box reagent kit, leveraging Organs-on-chips systems for studying diseases like non-alcoholic steatohepatitis. This innovative approach facilitates more accurate and cost-effective drug development, reflecting the impact of technology trends on product offerings in the biotechnology reagent market.

Product innovation stands out as a driving force in the biotechnology reagent market, with major companies investing in the development of novel products. For example, in May 2023, Bio-Techne's launch of Kappa and Lambda RNAscope in situ Hybridization Probes demonstrates a significant advancement in the detection of immunoglobulin mRNA, catering to research and clinical diagnostic communities. This emphasis on product innovation is a strategic move to meet evolving market needs and maintain a competitive edge.

In April 2022, Meridian Bioscience, a prominent US-based life science company, completed the acquisition of Euprotein Inc. This undisclosed transaction is expected to enhance Meridian's recombinant capabilities and expedite the development of novel immunological tools. Euprotein Inc. is a biotechnology company, specializes in the development and manufacturing of bioresearch reagents, aligning with Meridian Bioscience's commitment to advancing the field through strategic acquisitions.

Major companies operating in the biotechnology reagents market are Life Technologies Corporation, Abbott Laboratories, Abcam PLC, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Company, BioLegend Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology, Danaher Corp., General Electric incorporated, Hoefer Inc., Illumina Inc., Lonza Group Ltd., Merck KGaA Group, Meridian Bioscience Inc., Millipore Corporation, New England Biolabs Inc., Novus Biologicals LLC, PerkinElmer Inc., Promega Corporation, Quality Biological Inc., Roche Holding AG, Siemens Healthineers AG, Sigma-Aldrich Corp., Sysmex Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Tosoh Corporation.

North America was the largest region in the biotechnology reagents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biotechnology reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Biotechnology reagents are chemical compounds employed in the detection, measurement, and preparation of various products by facilitating chemical reactions. These reagents play a crucial role in quantifying and detecting specific substances, with their binding to the target substances triggering specific reactions.

The primary types of biotechnology reagents include life science reagents, analytical reagents, and other reagents. Life science reagents are substances utilized in chemical reactions to observe data changes and analyze this data to understand the causes of diseases. These reagents find applications in diverse areas such as protein synthesis and purification, gene expression, DNA and RNA analysis, and drug testing. End-users of biotechnology reagents encompass biotech companies, research institutes, pharmaceuticals, diagnostic centers, academic institutes, and other entities.

The biotechnology reagents market research report is one of a series of new reports that provides Biotechnology reagents market statistics, including Biotechnology reagents industry global market size, regional shares, competitors with a Biotechnology reagents market share, detailed Biotechnology reagents market segments, market trends and opportunities, and any further data you may need to thrive in the Biotechnology reagents industry. This Biotechnology reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biotechnology reagents market includes revenues earned by entities by chromatography, in-vitro diagnostics, polymerase chain reaction and cell culture technologies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.